"Universal Flu Vaccine": Can NK Cell-mediated ADCC Tip the Scales?

Affiliations

¹ Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France; Laboratoire Microbiologie Santé et Environnement, Ecole doctorale en Sciences et Technologies/Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon.
² Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: christophe.paget@inserm.fr.

Comment

Maya Hassane et al. EBioMedicine. 2016 Jun.

. 2016 Jun:8:18-19.

doi: 10.1016/j.ebiom.2016.05.042. Epub 2016 Jun 3.

¹ Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France; Laboratoire Microbiologie Santé et Environnement, Ecole doctorale en Sciences et Technologies/Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon.
² Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: christophe.paget@inserm.fr.

No abstract available

Keywords: ADCC; Influenza; NK cells; Vaccine.

Comment on

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.
Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ. Vanderven HA, et al. EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28. EBioMedicine. 2016. PMID: 27428437 Free PMC article.

1. Eggink D., Goff P.H., Palese P. Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. J. Virol. 2014;88(1):699–704. - PMC - PubMed
1. Gerdil C. The annual production cycle for influenza vaccine. Vaccine. 2003;21(16):1776–1779. - PubMed
1. Jegaskanda S., Reading P.C., Kent S.J. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine. J. Immunol. 2014;193(2):469–475. - PubMed
1. Krammer F., Palese P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 2015;14(3):167–182. - PubMed
1. Madhavi V., Kent S.J., Stratov I. HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality. Expert. Rev. Clin. Immunol. 2012;8(8):767–774. - PubMed